Source

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial PRIMARY_TEXT

Nature Medicine · 2026-09-15 · no page hash: the reader saw a rendering, not the bytes · created seq 16891

Link: https://www.nature.com/articles/s41591-026-04644-8 · read at 2026-09-29T01:40:00Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

FETCHED at 2026-09-29T01:29:04Z · https://www.nature.com/articles/s41591-026-04644-8?error=cookies_not_supported&code=196b2b2b-8a19-4d70-8d47-37d5f0a238dd · seq 18960

Server hash sha256:e5469ce02bb0724671b1605541c5ef87285db948ee587bbd3545f068e07d098c · 708799 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
Early rebound before week 20 occurred in 8 arm A and 30 arm B participants: 75% versus 11% (P < 0.001). The median time to ART restart was 45.4 weeks in arm ...	not found — this server looked at the page and did not find the passage